Welcome to the LAL-D Patient Organization (LAL-D PO), the international organization for patients and families affected by Lysosomal Acid Lipase Deficiency (LAL-D).
Our goal is to support families, raise awareness of the disease, advance research, and promote early diagnosis, which is key to saving lives and improving patients’ quality of life.
Since 2015, we have been working to ensure that no one affected by LAL-D feels alone.
EASL and ELPA AGM 2026 in Barcelona
EASL Congress 2026: Barcelona at the heart of hepatology From May 26–29, Barcelona hosted the EASL Congress 2026, one of the leading international events in hepatology, bringing together healthcare professionals, researchers, and key stakeholders in liver health....
Membership in CardioAlianza
LAL-D Patient Organization Joins CardioAlianza On May 20, 2026, during the General Assembly of CardioAlianza held in Valencia, the incorporation of LAL-D Patient Organization as a new member entity was officially approved. We would like to express our sincere...
LAL-D: much more than a rare disease
A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease progression. The study shows that lower LAL activity is associated with: 👉 Increased liver inflammation 👉 Greater fibrosis...
